Perceived clinical severity of atopic dermatitis in adolescents: Comparison between patients' and parents' evaluation - 05/12/20
Doi : 10.1016/j.jaad.2020.04.037
Khaled Ezzedine, MD, PhD a, Jason Shourick, DStat b, Stéphanie Merhand, PhD c, Francesca Sampogna, PhD d, Charles Taieb, MD e, f, g, ⁎ 
a Department of Dermatology, Hôpital Henri Mondor, EA EpiDermE (Epidémiologie en Dermatologie et Evaluation des Thérapeutiques), UPEC-Université Paris-Est Créteil, Créteil, France
b Biostatistician, Université Paris Sud, Paris, France
c Association Française de l’Eczema, Redon, France
d Clinical Epidemiology Unit, Istituto Dermopatico dell'Immacolata, Istituto di Ricovero e Cura a Carattere Scientifico (IDI-IRCCS), Rome, Italy
e Public Health, Hôpital Necker Enfants Malades, Paris, France
f European Market Maintenance Assessment, Vincennes, France
g Maison de la Dermatologie, Société Française des Sciences Humaines sur la Peau (SFSHP), Paris, France
∗Correspondence to: Charles Taieb, European Market Maintenance Assessment, 18 rue de la Renardière, 94120 Fontenay sous Bois, FranceEuropean Market Maintenance Assessment18 rue de la Renardière94120 Fontenay sous BoisFrance
| Funding sources: Sanofi-Genzyme. |
|
| Conflicts of interest: None disclosed. |
|
| IRB approval status: This study was reviewed and approved by Institutional Review Board Nord Ouest III, Caen, France on September 7, 2019, and conducted according to the Declaration of Helsinki. |
|
| Reprints not available from the authors. |
© 2020
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 84 - N° 1
P. 164-165 - janvier 2021 Retour au numéro
Article précédent
- Effect of anti–tumor necrosis factor therapy on the risk of respiratory tract infections and related symptoms in patients with psoriasis—A meta-estimate of pivotal phase 3 trials relevant to decision making during the COVID-19 pandemic
- Maha N. Syed, Mohsin Shah, Daniel B. Shin, Marilyn T. Wan, Kevin L. Winthrop, Joel M. Gelfand
- Safety of trimethoprim-sulfamethoxazole for Pneumocystis jirovecii pneumonia prophylaxis in patients taking methotrexate
- Sonia A. Havele, Ariana Ellis, Alex Chaitoff, Urmi Khanna, Joseph Parambil, Carol A. Langford, Anthony P. Fernandez
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?